NCT00002440View on ClinicalTrials.gov

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Ritonavir

DRUG

Abacavir sulfate

DRUG

Amprenavir

DRUG

Nelfinavir mesylate

DRUG

Saquinavir

Trial Locations (8)

10016

NYU Med Ctr / Dept of Medicine / AIDS Clinical Trial, New York

15213

Univ of Pittsburgh Med Ctr, Pittsburgh

28232

Carolinas Med Ctr, Charlotte

44106

Case Western Reserve Univ / AIDS Clinical Trials Unit, Cleveland

64111

Kansas City AIDS Research Consortium, Kansas City

372321302

Vanderbilt Univ Med Ctr, Nashville

921036329

UCSD Treatment Ctr, San Diego

065102483

Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit, New Haven

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002440 - A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs | Biotech Hunter | Biotech Hunter